47 results
8-K
EX-1.1
ALLO
Allogene Therapeutics Inc
14 May 24
Other Events
4:40pm
in the ordinary course of business pursuant to the Company’s equity plans that are described in the Pricing Prospectus) or long-term debt of the Company
8-K
EX-99.1
c55 dm5z7bb
2 Nov 23
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
4:03pm
8-K
EX-99.1
wi21f
2 Aug 23
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
4:04pm
8-K
elvbm2
7 Jun 23
Other Events
4:16pm
SC TO-I
EX-99
sdnum vw9pv7bo0f
21 Jun 22
Issuer tender offer statement
9:05am
SC TO-I
EX-99
mq38j
21 Jun 22
Issuer tender offer statement
9:05am
8-K
EX-99.1
1eff9jhj6jj oz9ajs
4 May 22
Allogene Therapeutics Reports First Quarter 2022 Financial Results
4:09pm